Again in the absence of initiating mutations, deletion of Tgfbr1 did not result in tumor formation, but with DMBA treatment HNSCC developed in approximately half of the mice, preceded by enhanced proliferation and decreased apoptosis in basal epithelial cells and activation of the PI3-kinase/AKT pathway [51]. The gene discussed is TGFBR1; the disease is neoplasm.